Biotech
ICoNS 2026
ICoNS welcomes thought-leaders across all fields that are actively participating in newborn sequencing implementation projects, or are imminently preparing to do so. Oxford Nanopore are sponsoring and exhibiting at this event.
3Speakers
1Sponsors
1Exhibitors
3On the bill · sessions
4Companies · in total
Speakers
Programmed at ICoNS, in alphabetical order.Eric Joo
University of Melbourne
Neblina Sikta
Clinical Bioinformatician · Victorian Clinical Genetics Services (VCGS)
Zoe Ward
University of Auckland
Sponsors
The houses behind the program. Tiers as disclosed.Agenda
Selected from 3 sessions on the bill.- Monday, 3 August 2026 | 14:45 - 15:05Oxford Nanopore Industry Session
Using Oxford Nanopore Technologies long-read sequencing to resolve unexplained hereditary colorectal cancer and polyposis syndrome patients
Background: Current hereditary colorectal cancer multigene panel testing uses conventional short-read next-generation sequencing, which can miss complex genetic variations such as …
- Monday, 3 August 2026 | 15:05 - 15:25Oxford Nanopore Industry Session
Genetic testing solves mystery of teens’ sudden deaths
- Monday, 3 August 2026 | 15:25 - 15:45Oxford Nanopore Industry Session
Genome-wide phasing using routine clinical samples
Accurate haplotype phasing is critical for clinical variant interpretation, particularly for resolving cis/trans relationships in recessive Mendelian disease. Long-read sequencing …
Intermission
Part the Second · For the Buyer
What does it mean when 4 companies show up, and 1 bet on three roles at once?
Four companies. one are betting more than once.
The numbers below are derived from the speakers, sponsors, and exhibitors on this page, cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.
1All threespeak · spons · exh
0Sponsoringsponsor only
0Exhibitingexhibitor only
3Companies Speakingspeaker only
The Triple-Threat
- Other roles3100%
Of 3 on the bill · classified by free-text title
unspecified1
100% of 1